Paper6756459
The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.
Smith SR and 3 others. Br J Cancer, 1982. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy. Papers, record 6756459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6756459
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Carcinoembryonic Antigen | Major topic |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Immunoenzyme Techniques | |
| Lymphatic Metastasis | |
| Prognosis |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6059522 | Sensitivity of L cells in exponential and stationary phase to 5-fluorouracil. | Nature | 1967 | https://conductscience.org/library/papers/6059522 | PubMed |
| 2 | 5121665 | Sensitivity to nitrogen mustard as a function of transport activity and proliferative rate in L5178Y lymphoblasts. | Cancer Res | 1971 | https://conductscience.org/library/papers/5121665 | PubMed |
| 3 | 4823478 | Carcinoembryonic antigen in breast cancer patients: serum levels and disease progress. | Cancer | 1974 | https://conductscience.org/library/papers/4823478 | PubMed |
| 4 | 4858112 | Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin. | Cancer Res | 1974 | https://conductscience.org/library/papers/4858112 | PubMed |
| 5 | 1110084 | Prognostic factors in colon carcinoma: correlation of serum carcinoembryonic antigen level and tumor histopathology. | Hum Pathol | 1975 | https://conductscience.org/library/papers/1110084 | PubMed |
| 6 | 1094196 | Carcinoembryonic antigen (CEA) levels and tumor histology in colon cancer. | J Surg Res | 1975 | https://conductscience.org/library/papers/1094196 | PubMed |
| 7 | 1156523 | Changes in sensitivity to cytotoxic agents occurring during the life history of monolayer cultures of a mouse tumour cell line. | Br J Cancer | 1975 | https://conductscience.org/library/papers/1156523 | PubMed |
| 8 | 964319 | Restriction of CEA synthesis to the stationary phase of growth of cultured human colon carcinoma cells. | Exp Cell Res | 1976 | https://conductscience.org/library/papers/964319 | PubMed |
| 9 | 872038 | Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen. | Cancer | 1977 | https://conductscience.org/library/papers/872038 | PubMed |
| 10 | 872092 | Antibody-dependent cell-mediated cytolysis of human colon carcinoma cells induced by specific antisera against carcinoembryonic antigen. | Cancer Res | 1977 | https://conductscience.org/library/papers/872092 | PubMed |
| 11 | 873641 | K cell mediated lysis of cultured colon carcinoma and urinary bladder carcinoma cells induced by monospecific antisera against carcinoembryonic antigen (CEA) and two CEA-related normal glycoproteins. | Int J Cancer | 1977 | https://conductscience.org/library/papers/873641 | PubMed |
| 12 | 406560 | Acute leukemia after alkylating-agent therapy of ovarian cancer. | N Engl J Med | 1977 | https://conductscience.org/library/papers/406560 | PubMed |
| 13 | 278642 | Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/278642 | PubMed |
| 14 | 698698 | Natural history and prognosis of recurrent breast cancer. | Br Med J | 1978 | https://conductscience.org/library/papers/698698 | PubMed |
| 15 | 698917 | Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy. | Cancer | 1978 | https://conductscience.org/library/papers/698917 | PubMed |
| 16 | 365699 | Correlation of carcinoembryonic antigen in tissue sections with spread of mammary carcinoma. | Histopathology | 1978 | https://conductscience.org/library/papers/365699 | PubMed |
| 17 | 435793 | Carcinoembryonic antigen in breast-cancer tissue: a useful prognostic indicator. | Br Med J | 1979 | https://conductscience.org/library/papers/435793 | PubMed |
| 18 | 108040 | Circulating carcinoembryonic antigen immune complexes in sera of patients with carcinomata of the gastrointestinal tract. | Clin Exp Immunol | 1979 | https://conductscience.org/library/papers/108040 | PubMed |
| 19 | 476707 | Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapy. | Cancer Treat Rep | 1979 | https://conductscience.org/library/papers/476707 | PubMed |
| 20 | 480384 | Human colon adenocarcinoma cells. III. In vitro organoid expression and carcinoembryonic antigen kinetics in hollow fiber culture. | J Natl Cancer Inst | 1979 | https://conductscience.org/library/papers/480384 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6511807 | Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis? | J Cancer Res Clin Oncol | 1984 | https://conductscience.org/library/papers/6511807 | PubMed |
| 6203639 | The detection and evaluation of human tumor metastases. | Cancer Metastasis Rev | 1983 | https://conductscience.org/library/papers/6203639 | PubMed |
| 3682432 | Immunohistochemical demonstration of estrogen, progesterone, CEA and ferritin in breast cancer and their clinical value for the prediction of early postoperative recurrence. | Jpn J Surg | 1987 | https://conductscience.org/library/papers/3682432 | PubMed |
| 1649933 | The clinical value of tissue carcinoembryonic antigen in breast cancer. | Jpn J Surg | 1991 | https://conductscience.org/library/papers/1649933 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CEACAM3 | 1084 | PubTator's text mining | https://conductscience.org/library/genes/1084 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6756459
GET https://conductscience.org/api/papers/v1/6756459/references?page=2